News
  Damora Therapeutics begins phase 1/1b CLARITY-101 trial of DMR-001 in patients with mutant calreticulin-driven essential thrombocythemia and myelofibrosis,   August 06, 2026
  Marvel Biosciences announces positive results from preclinical Fragile X study conducted through the FRAXA Drug Validation Initiative,   August 06, 2026
  4Moving Biotech completes enrollment in phase 2a INFLAM MOTION study evaluating first-in-class intra-articular GLP-1 therapy?targeting synovitis as a driver of pain and disease progression in knee osteoarthritis,   August 05, 2026
  Evexta Bio enters clinical trial collaboration and supply agreement with Roche to evaluate rupitasertib in combo with a SERD in advanced/metastatic breast cancer,   August 05, 2026
  Otsuka unveils unprecedented phase 3 VISIONARY two-year eGFR results demonstrating Voyxact stabilizes kidney function decline to baseline physiologic rate, fundamentally altering disease progression in IgAN,   August 05, 2026
  Keenova Therapeutics announces publication of Xiaflex manuscript in Translational Andrology and Urology,   August 04, 2026
  Invenio Imaging completes enrollment in ON-SITE study, an AI-based image analysis for lung cancer,   August 04, 2026
  AusperBio begins patient dosing in clinical study of AHB-171, a siRNA therapeutic candidate for chronic hepatitis B,   August 04, 2026
  Tiziana Life Sciences announces reduction in brain inflammation in third multiple system atrophy patient treated with intranasal foralumab,   August 03, 2026
  EyePoint completes enrollment of both pivotal phase 3 trials of Duravyu to treat diabetic macular edema,   August 03, 2026
  Moleculin Biotech announces positive results from pivotal phase 2/3 MIRACLE trial of Annamycin in combo with cytarabine to treat r/r acute myeloid leukaemia,   August 03, 2026
  US FDA clears Iksuda Therapeutics’ IND application for IKS04, a CA242-directed ADC to treat patients with GI cancers,   August 01, 2026
  Atavistik Bio partners with Cure HHT Clinical Trial Network to advance development of ATV-1601 for hereditary haemorrhagic telangiectasia,   August 01, 2026
  Lokahi Therapeutics advances LT-100 development strategy toward single-injection administration,   July 31, 2026
  Pfizer reports positive topline phase 3 results for Litfulo in patients with nonsegmental vitiligo,   July 31, 2026
  Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026,   July 31, 2026
  MannKind announces positive results from phase 1b INFLO-1 study of nintedanib DPI to treat idiopathic pulmonary fibrosis IPF,   July 30, 2026
  UK - Japan clinical trials collaboration on children and young people’s cancers,   July 30, 2026
  GSK’s licensor Hansoh Pharma announces positive results from a second phase III trial for Ris-Rez in China,   July 30, 2026
  Akeso begins patient dosing in phase Ib/II study of HER3 ADC (AK138D1) combined with ivonescimab in lung cancer,   July 29, 2026

Results Found: 17150

Go to Total Number of Pages: 858
 Back
Copyright © 2016 Saffron Media Pvt. Ltd |
counter